#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=4. Discussion
1-1	0-2	4.	_	_	_	_
1-2	3-13	Discussion	abstract	new	_	_

#Text=The biochemical and structural analyses of a new haloalkane dehalogenase DmxA from Antarctic bacterium Marinobacter sp. ELB17 revealed the paradoxical stability of the enzyme .
2-1	14-17	The	abstract[2]	new[2]	_	_
2-2	18-29	biochemical	abstract[2]	new[2]	_	_
2-3	30-33	and	abstract[2]	new[2]	_	_
2-4	34-44	structural	abstract[2]	new[2]	_	_
2-5	45-53	analyses	abstract[2]	new[2]	_	_
2-6	54-56	of	abstract[2]	new[2]	_	_
2-7	57-58	a	abstract[2]|abstract[5]	new[2]|new[5]	coref	3-6[0_5]
2-8	59-62	new	abstract[2]|abstract[5]	new[2]|new[5]	_	_
2-9	63-73	haloalkane	abstract[2]|object|abstract[4]|abstract[5]	new[2]|new|new[4]|new[5]	_	_
2-10	74-86	dehalogenase	abstract[2]|abstract[4]|abstract[5]	new[2]|new[4]|new[5]	_	_
2-11	87-91	DmxA	abstract[2]|abstract[5]	new[2]|new[5]	_	_
2-12	92-96	from	abstract[2]	new[2]	_	_
2-13	97-106	Antarctic	abstract[2]|animal[6]|person[7]	new[2]|new[6]|new[7]	_	_
2-14	107-116	bacterium	abstract[2]|animal[6]|person[7]	new[2]|new[6]|new[7]	_	_
2-15	117-129	Marinobacter	abstract[2]|person[7]	new[2]|new[7]	_	_
2-16	130-133	sp.	_	_	_	_
2-17	134-139	ELB17	abstract	new	_	_
2-18	140-148	revealed	_	_	_	_
2-19	149-152	the	abstract[9]	new[9]	coref	8-25[60_9]
2-20	153-164	paradoxical	abstract[9]	new[9]	_	_
2-21	165-174	stability	abstract[9]	new[9]	_	_
2-22	175-177	of	abstract[9]	new[9]	_	_
2-23	178-181	the	abstract[9]|substance[10]	new[9]|new[10]	ana	3-2[0_10]
2-24	182-188	enzyme	abstract[9]|substance[10]	new[9]|new[10]	_	_
2-25	189-190	.	_	_	_	_

#Text=Despite its psychrophilic origin , DmxA wt exhibited the highest apparent melting temperature ( T m , app = 65.9 ± 0.1 ° C ) of all biochemically characterized HLD-II members , and the second highest of all thus far characterized wild-type HLDs .
3-1	191-198	Despite	_	_	_	_
3-2	199-202	its	substance|abstract[12]	giv|new[12]	coref|coref	5-1[35_0]|8-11[57_12]
3-3	203-216	psychrophilic	abstract[12]	new[12]	_	_
3-4	217-223	origin	abstract[12]	new[12]	_	_
3-5	224-225	,	_	_	_	_
3-6	226-230	DmxA	abstract	giv	coref	4-10
3-7	231-233	wt	_	_	_	_
3-8	234-243	exhibited	_	_	_	_
3-9	244-247	the	abstract[15]	new[15]	coref	4-5[26_15]
3-10	248-255	highest	abstract[15]	new[15]	_	_
3-11	256-264	apparent	abstract[15]	new[15]	_	_
3-12	265-272	melting	event|abstract[15]	new|new[15]	coref	4-7
3-13	273-284	temperature	abstract[15]	new[15]	_	_
3-14	285-286	(	_	_	_	_
3-15	287-288	T	person|abstract[17]	new|new[17]	coref|coref	5-12[39_17]|21-20
3-16	289-290	m	abstract[17]	new[17]	_	_
3-17	291-292	,	_	_	_	_
3-18	293-296	app	abstract	new	coref	5-15
3-19	297-298	=	_	_	_	_
3-20	299-303	65.9	abstract[19]	new[19]	_	_
3-21	304-305	±	abstract[19]	new[19]	_	_
3-22	306-309	0.1	abstract[19]	new[19]	_	_
3-23	310-311	°	abstract[19]	new[19]	_	_
3-24	312-313	C	abstract[19]	new[19]	_	_
3-25	314-315	)	_	_	_	_
3-26	316-318	of	_	_	_	_
3-27	319-322	all	person[21]	new[21]	coref	17-29[145_21]
3-28	323-336	biochemically	person[21]	new[21]	_	_
3-29	337-350	characterized	person[21]	new[21]	_	_
3-30	351-357	HLD-II	abstract|person[21]	new|new[21]	coref	17-34
3-31	358-365	members	person[21]	new[21]	_	_
3-32	366-367	,	_	_	_	_
3-33	368-371	and	_	_	_	_
3-34	372-375	the	_	_	_	_
3-35	376-382	second	_	_	_	_
3-36	383-390	highest	_	_	_	_
3-37	391-393	of	_	_	_	_
3-38	394-397	all	abstract[23]	new[23]	coref	23-8[0_23]
3-39	398-402	thus	abstract[23]	new[23]	_	_
3-40	403-406	far	abstract[23]	new[23]	_	_
3-41	407-420	characterized	abstract[23]	new[23]	_	_
3-42	421-430	wild-type	abstract|abstract[23]	new|new[23]	_	_
3-43	431-435	HLDs	abstract[23]	new[23]	_	_
3-44	436-437	.	_	_	_	_

#Text=The only HLD exhibiting higher apparent melting temperature than DmxA was DhmeA from halophilic archaea Haloferax mediterranei ATCC 33500 , which belongs to the subfamily HLD-III .
4-1	438-441	The	abstract[24]	new[24]	coref	11-8[0_24]
4-2	442-446	only	abstract[24]	new[24]	_	_
4-3	447-450	HLD	abstract[24]	new[24]	_	_
4-4	451-461	exhibiting	abstract[24]	new[24]	_	_
4-5	462-468	higher	abstract[24]|abstract[26]	new[24]|giv[26]	coref	21-8[173_26]
4-6	469-477	apparent	abstract[24]|abstract[26]	new[24]|giv[26]	_	_
4-7	478-485	melting	abstract[24]|event|abstract[26]	new[24]|giv|giv[26]	coref	21-9
4-8	486-497	temperature	abstract[24]|abstract[26]	new[24]|giv[26]	_	_
4-9	498-502	than	abstract[24]|abstract[26]	new[24]|giv[26]	_	_
4-10	503-507	DmxA	abstract[24]|abstract[26]|abstract	new[24]|giv[26]|giv	coref	6-18
4-11	508-511	was	_	_	_	_
4-12	512-517	DhmeA	person[28]	new[28]	_	_
4-13	518-522	from	person[28]	new[28]	_	_
4-14	523-533	halophilic	person[28]|animal[29]|abstract[30]	new[28]|new[29]|new[30]	_	_
4-15	534-541	archaea	person[28]|animal[29]|abstract[30]	new[28]|new[29]|new[30]	_	_
4-16	542-551	Haloferax	person[28]|abstract[30]	new[28]|new[30]	_	_
4-17	552-564	mediterranei	abstract	new	appos	4-18[33_0]
4-18	565-569	ATCC	organization|abstract[33]	new|giv[33]	_	_
4-19	570-575	33500	abstract[33]	giv[33]	_	_
4-20	576-577	,	_	_	_	_
4-21	578-583	which	_	_	_	_
4-22	584-591	belongs	_	_	_	_
4-23	592-594	to	_	_	_	_
4-24	595-598	the	animal[34]	new[34]	coref	5-5[37_34]
4-25	599-608	subfamily	animal[34]	new[34]	_	_
4-26	609-616	HLD-III	animal[34]	new[34]	_	_
4-27	617-618	.	_	_	_	_

#Text=The enzyme DhmeA from subfamily HLD-III is a multimeric protein with T m , app = 70.6 ° C.
5-1	619-622	The	substance[35]|substance[36]	giv[35]|new[36]	coref|coref	5-8[38_36]|13-35[113_35]
5-2	623-629	enzyme	substance[35]|substance[36]	giv[35]|new[36]	_	_
5-3	630-635	DhmeA	substance[36]	new[36]	_	_
5-4	636-640	from	substance[36]	new[36]	_	_
5-5	641-650	subfamily	substance[36]|animal[37]	new[36]|giv[37]	coref	17-32[146_37]
5-6	651-658	HLD-III	substance[36]|animal[37]	new[36]|giv[37]	_	_
5-7	659-661	is	_	_	_	_
5-8	662-663	a	substance[38]	giv[38]	coref	6-5[0_38]
5-9	664-674	multimeric	substance[38]	giv[38]	_	_
5-10	675-682	protein	substance[38]	giv[38]	_	_
5-11	683-687	with	substance[38]	giv[38]	_	_
5-12	688-689	T	substance[38]|abstract[39]	giv[38]|giv[39]	coref	21-20[178_39]
5-13	690-691	m	substance[38]|abstract[39]	giv[38]|giv[39]	_	_
5-14	692-693	,	substance[38]	giv[38]	_	_
5-15	694-697	app	substance[38]|abstract	giv[38]|giv	_	_
5-16	698-699	=	substance[38]	giv[38]	_	_
5-17	700-704	70.6	substance[38]|abstract[41]	giv[38]|new[41]	_	_
5-18	705-706	°	substance[38]|abstract[41]	giv[38]|new[41]	_	_
5-19	707-709	C.	substance[38]|abstract[41]	giv[38]|new[41]	_	_

#Text=The tertiary structure of DhmeA is not available at this moment , preventing its direct comparison with DmxA .
6-1	710-713	The	abstract[42]	new[42]	ana	6-14[0_42]
6-2	714-722	tertiary	abstract[42]	new[42]	_	_
6-3	723-732	structure	abstract[42]	new[42]	_	_
6-4	733-735	of	abstract[42]	new[42]	_	_
6-5	736-741	DhmeA	abstract[42]|substance	new[42]|giv	coref	13-4
6-6	742-744	is	_	_	_	_
6-7	745-748	not	_	_	_	_
6-8	749-758	available	_	_	_	_
6-9	759-761	at	_	_	_	_
6-10	762-766	this	time[44]	new[44]	_	_
6-11	767-773	moment	time[44]	new[44]	_	_
6-12	774-775	,	_	_	_	_
6-13	776-786	preventing	_	_	_	_
6-14	787-790	its	abstract|abstract[46]	giv|new[46]	coref	8-34[62_0]
6-15	791-797	direct	abstract[46]	new[46]	_	_
6-16	798-808	comparison	abstract[46]	new[46]	_	_
6-17	809-813	with	abstract[46]	new[46]	_	_
6-18	814-818	DmxA	abstract[46]|abstract	new[46]|giv	coref	9-9
6-19	819-820	.	_	_	_	_

#Text=Several thermostable enzymes from psychrophiles and mesophiles have been reported in the literature ; however , their unexpected thermostability remains poorly understood .
7-1	821-828	Several	substance[48]	new[48]	coref	8-6[56_48]
7-2	829-841	thermostable	substance[48]	new[48]	_	_
7-3	842-849	enzymes	substance[48]	new[48]	_	_
7-4	850-854	from	substance[48]	new[48]	_	_
7-5	855-868	psychrophiles	substance[48]|abstract|abstract[50]	new[48]|new|new[50]	ana	7-17[0_50]
7-6	869-872	and	substance[48]|abstract[50]	new[48]|new[50]	_	_
7-7	873-883	mesophiles	substance[48]|abstract[50]|person	new[48]|new[50]|new	_	_
7-8	884-888	have	_	_	_	_
7-9	889-893	been	_	_	_	_
7-10	894-902	reported	_	_	_	_
7-11	903-905	in	_	_	_	_
7-12	906-909	the	abstract[52]	new[52]	_	_
7-13	910-920	literature	abstract[52]	new[52]	_	_
7-14	921-922	;	_	_	_	_
7-15	923-930	however	_	_	_	_
7-16	931-932	,	_	_	_	_
7-17	933-938	their	abstract|abstract[54]	giv|new[54]	_	_
7-18	939-949	unexpected	abstract[54]	new[54]	_	_
7-19	950-965	thermostability	abstract[54]	new[54]	_	_
7-20	966-973	remains	_	_	_	_
7-21	974-980	poorly	_	_	_	_
7-22	981-991	understood	_	_	_	_
7-23	992-993	.	_	_	_	_

#Text=Only two studies focused on such paradoxically thermostable enzymes from psychrophilic and mesophilic origin have attempted so far to explain the structural basis of their stability , suggesting that either the flexibility of a global structure or the presence of extra disulfide and salt bridges are responsible for the unusual thermal stability of these enzymes .
8-1	994-998	Only	abstract[55]	new[55]	_	_
8-2	999-1002	two	abstract[55]	new[55]	_	_
8-3	1003-1010	studies	abstract[55]	new[55]	_	_
8-4	1011-1018	focused	abstract[55]	new[55]	_	_
8-5	1019-1021	on	abstract[55]	new[55]	_	_
8-6	1022-1026	such	abstract[55]|substance[56]	new[55]|giv[56]	ana	8-25[0_56]
8-7	1027-1040	paradoxically	abstract[55]|substance[56]	new[55]|giv[56]	_	_
8-8	1041-1053	thermostable	abstract[55]|substance[56]	new[55]|giv[56]	_	_
8-9	1054-1061	enzymes	abstract[55]|substance[56]	new[55]|giv[56]	_	_
8-10	1062-1066	from	abstract[55]|substance[56]	new[55]|giv[56]	_	_
8-11	1067-1080	psychrophilic	abstract[55]|substance[56]|abstract[57]	new[55]|giv[56]|giv[57]	_	_
8-12	1081-1084	and	abstract[55]|substance[56]|abstract[57]	new[55]|giv[56]|giv[57]	_	_
8-13	1085-1095	mesophilic	abstract[55]|substance[56]|abstract[57]	new[55]|giv[56]|giv[57]	_	_
8-14	1096-1102	origin	abstract[55]|substance[56]|abstract[57]	new[55]|giv[56]|giv[57]	_	_
8-15	1103-1107	have	_	_	_	_
8-16	1108-1117	attempted	_	_	_	_
8-17	1118-1120	so	_	_	_	_
8-18	1121-1124	far	_	_	_	_
8-19	1125-1127	to	_	_	_	_
8-20	1128-1135	explain	_	_	_	_
8-21	1136-1139	the	abstract[58]	new[58]	_	_
8-22	1140-1150	structural	abstract[58]	new[58]	_	_
8-23	1151-1156	basis	abstract[58]	new[58]	_	_
8-24	1157-1159	of	abstract[58]	new[58]	_	_
8-25	1160-1165	their	abstract[58]|substance|abstract[60]	new[58]|giv|giv[60]	coref	8-54[68_0]
8-26	1166-1175	stability	abstract[58]|abstract[60]	new[58]|giv[60]	_	_
8-27	1176-1177	,	_	_	_	_
8-28	1178-1188	suggesting	_	_	_	_
8-29	1189-1193	that	_	_	_	_
8-30	1194-1200	either	abstract[61]	new[61]	_	_
8-31	1201-1204	the	abstract[61]	new[61]	_	_
8-32	1205-1216	flexibility	abstract[61]	new[61]	_	_
8-33	1217-1219	of	abstract[61]	new[61]	_	_
8-34	1220-1221	a	abstract[61]|abstract[62]	new[61]|giv[62]	ana	9-17[0_62]
8-35	1222-1228	global	abstract[61]|abstract[62]	new[61]|giv[62]	_	_
8-36	1229-1238	structure	abstract[61]|abstract[62]	new[61]|giv[62]	_	_
8-37	1239-1241	or	_	_	_	_
8-38	1242-1245	the	abstract[63]	new[63]	coref	14-7[116_63]
8-39	1246-1254	presence	abstract[63]	new[63]	_	_
8-40	1255-1257	of	abstract[63]	new[63]	_	_
8-41	1258-1263	extra	abstract[63]|object[66]	new[63]|new[66]	_	_
8-42	1264-1273	disulfide	abstract[63]|place|object[66]	new[63]|new|new[66]	coref	16-4
8-43	1274-1277	and	abstract[63]|object[66]	new[63]|new[66]	_	_
8-44	1278-1282	salt	abstract[63]|substance|object[66]	new[63]|new|new[66]	_	_
8-45	1283-1290	bridges	abstract[63]|object[66]	new[63]|new[66]	_	_
8-46	1291-1294	are	_	_	_	_
8-47	1295-1306	responsible	_	_	_	_
8-48	1307-1310	for	_	_	_	_
8-49	1311-1314	the	abstract[67]	new[67]	coref	9-17[74_67]
8-50	1315-1322	unusual	abstract[67]	new[67]	_	_
8-51	1323-1330	thermal	abstract[67]	new[67]	_	_
8-52	1331-1340	stability	abstract[67]	new[67]	_	_
8-53	1341-1343	of	abstract[67]	new[67]	_	_
8-54	1344-1349	these	abstract[67]|substance[68]	new[67]|giv[68]	_	_
8-55	1350-1357	enzymes	abstract[67]|substance[68]	new[67]|giv[68]	_	_
8-56	1358-1359	.	_	_	_	_

#Text=In this study , several structural features of DmxA wt were analyzed in detail to explain its extraordinary stability .
9-1	1360-1362	In	_	_	_	_
9-2	1363-1367	this	abstract[69]	new[69]	_	_
9-3	1368-1373	study	abstract[69]	new[69]	_	_
9-4	1374-1375	,	_	_	_	_
9-5	1376-1383	several	abstract[70]	new[70]	_	_
9-6	1384-1394	structural	abstract[70]	new[70]	_	_
9-7	1395-1403	features	abstract[70]	new[70]	_	_
9-8	1404-1406	of	abstract[70]	new[70]	_	_
9-9	1407-1411	DmxA	abstract[70]|abstract|abstract[72]	new[70]|giv|new[72]	coref|coref	10-1|17-13[0_72]
9-10	1412-1414	wt	abstract[70]|abstract[72]	new[70]|new[72]	_	_
9-11	1415-1419	were	_	_	_	_
9-12	1420-1428	analyzed	_	_	_	_
9-13	1429-1431	in	_	_	_	_
9-14	1432-1438	detail	_	_	_	_
9-15	1439-1441	to	_	_	_	_
9-16	1442-1449	explain	_	_	_	_
9-17	1450-1453	its	abstract|abstract[74]	giv|giv[74]	coref|coref	13-29[110_74]|17-16[142_0]
9-18	1454-1467	extraordinary	abstract[74]	giv[74]	_	_
9-19	1468-1477	stability	abstract[74]	giv[74]	_	_
9-20	1478-1479	.	_	_	_	_

#Text=DmxA wt was found to form a dimer via a cysteine bridge , which may be formed only after heterologous expression in E. coli and purification , while is less likely to occur in the cytoplasm of the original host organism .
10-1	1480-1484	DmxA	abstract|person[76]	giv|new[76]	coref|coref	13-16|13-17[0_76]
10-2	1485-1487	wt	person[76]	new[76]	_	_
10-3	1488-1491	was	_	_	_	_
10-4	1492-1497	found	_	_	_	_
10-5	1498-1500	to	_	_	_	_
10-6	1501-1505	form	abstract	new	coref|none	13-20[108_0]|10-6[0_108]
10-7	1506-1507	a	abstract[77]	new[77]	coref	15-33[131_77]
10-8	1508-1513	dimer	abstract[77]	new[77]	_	_
10-9	1514-1517	via	_	_	_	_
10-10	1518-1519	a	object[79]	new[79]	coref	13-12[103_79]
10-11	1520-1528	cysteine	place|object[79]	new|new[79]	coref	14-13
10-12	1529-1535	bridge	object[79]	new[79]	_	_
10-13	1536-1537	,	object[79]	new[79]	_	_
10-14	1538-1543	which	object[79]	new[79]	_	_
10-15	1544-1547	may	object[79]	new[79]	_	_
10-16	1548-1550	be	object[79]	new[79]	_	_
10-17	1551-1557	formed	object[79]	new[79]	_	_
10-18	1558-1562	only	object[79]	new[79]	_	_
10-19	1563-1568	after	object[79]	new[79]	_	_
10-20	1569-1581	heterologous	object[79]|event[80]	new[79]|new[80]	ana	11-1[0_80]
10-21	1582-1592	expression	object[79]|event[80]	new[79]|new[80]	_	_
10-22	1593-1595	in	object[79]|event[80]	new[79]|new[80]	_	_
10-23	1596-1598	E.	object[79]|event[80]|person|substance[82]	new[79]|new[80]|new|new[82]	_	_
10-24	1599-1603	coli	object[79]|event[80]|substance[82]	new[79]|new[80]|new[82]	_	_
10-25	1604-1607	and	object[79]|event[80]	new[79]|new[80]	_	_
10-26	1608-1620	purification	object[79]|event[80]|abstract	new[79]|new[80]|new	_	_
10-27	1621-1622	,	_	_	_	_
10-28	1623-1628	while	_	_	_	_
10-29	1629-1631	is	_	_	_	_
10-30	1632-1636	less	_	_	_	_
10-31	1637-1643	likely	_	_	_	_
10-32	1644-1646	to	_	_	_	_
10-33	1647-1652	occur	_	_	_	_
10-34	1653-1655	in	_	_	_	_
10-35	1656-1659	the	substance[84]	new[84]	_	_
10-36	1660-1669	cytoplasm	substance[84]	new[84]	_	_
10-37	1670-1672	of	substance[84]	new[84]	_	_
10-38	1673-1676	the	substance[84]|animal[86]	new[84]|new[86]	_	_
10-39	1677-1685	original	substance[84]|animal[86]	new[84]|new[86]	_	_
10-40	1686-1690	host	substance[84]|animal|animal[86]	new[84]|new|new[86]	_	_
10-41	1691-1699	organism	substance[84]|animal[86]	new[84]|new[86]	_	_
10-42	1700-1701	.	_	_	_	_

#Text=This is the first observation ever of HLD oligomerization mediated by the covalent bond .
11-1	1702-1706	This	event	giv	coref	11-3[88_0]
11-2	1707-1709	is	_	_	_	_
11-3	1710-1713	the	event[88]	giv[88]	_	_
11-4	1714-1719	first	event[88]	giv[88]	_	_
11-5	1720-1731	observation	event[88]	giv[88]	_	_
11-6	1732-1736	ever	event[88]	giv[88]	_	_
11-7	1737-1739	of	event[88]	giv[88]	_	_
11-8	1740-1743	HLD	event[88]|abstract|event[90]	giv[88]|giv|new[90]	coref	18-1[148_0]
11-9	1744-1759	oligomerization	event[88]|event[90]	giv[88]|new[90]	_	_
11-10	1760-1768	mediated	event[88]|event[90]	giv[88]|new[90]	_	_
11-11	1769-1771	by	event[88]|event[90]	giv[88]|new[90]	_	_
11-12	1772-1775	the	event[88]|event[90]|abstract[91]	giv[88]|new[90]|new[91]	_	_
11-13	1776-1784	covalent	event[88]|event[90]|abstract[91]	giv[88]|new[90]|new[91]	_	_
11-14	1785-1789	bond	event[88]|event[90]|abstract[91]	giv[88]|new[90]|new[91]	_	_
11-15	1790-1791	.	_	_	_	_

#Text=Thus far , the reported dimers of DbjA and DbeA were formed through the hydrophobic interactions of C-terminal α-helices .
12-1	1792-1796	Thus	_	_	_	_
12-2	1797-1800	far	_	_	_	_
12-3	1801-1802	,	_	_	_	_
12-4	1803-1806	the	abstract[92]	new[92]	_	_
12-5	1807-1815	reported	abstract[92]	new[92]	_	_
12-6	1816-1822	dimers	abstract[92]	new[92]	_	_
12-7	1823-1825	of	abstract[92]	new[92]	_	_
12-8	1826-1830	DbjA	abstract[92]|abstract	new[92]|new	_	_
12-9	1831-1834	and	abstract[92]	new[92]	_	_
12-10	1835-1839	DbeA	abstract[92]|substance	new[92]|new	_	_
12-11	1840-1844	were	_	_	_	_
12-12	1845-1851	formed	_	_	_	_
12-13	1852-1859	through	_	_	_	_
12-14	1860-1863	the	event[95]	new[95]	coref	21-37[184_95]
12-15	1864-1875	hydrophobic	event[95]	new[95]	_	_
12-16	1876-1888	interactions	event[95]	new[95]	_	_
12-17	1889-1891	of	event[95]	new[95]	_	_
12-18	1892-1902	C-terminal	event[95]|place|organization[97]	new[95]|new|new[97]	_	_
12-19	1903-1912	α-helices	event[95]|organization[97]	new[95]|new[97]	_	_
12-20	1913-1914	.	_	_	_	_

#Text=Although cysteines in protein structures often serve as stabilizing elements , the S-S bridge between DmxA wt units in its dimeric form did not have any effect on the stability or the activity of the enzyme .
13-1	1915-1923	Although	_	_	_	_
13-2	1924-1933	cysteines	substance[98]	new[98]	_	_
13-3	1934-1936	in	substance[98]	new[98]	_	_
13-4	1937-1944	protein	substance[98]|substance|abstract[100]	new[98]|giv|new[100]	coref|coref	21-41|26-20[224_100]
13-5	1945-1955	structures	substance[98]|abstract[100]	new[98]|new[100]	_	_
13-6	1956-1961	often	_	_	_	_
13-7	1962-1967	serve	_	_	_	_
13-8	1968-1970	as	_	_	_	_
13-9	1971-1982	stabilizing	abstract[101]	new[101]	_	_
13-10	1983-1991	elements	abstract[101]	new[101]	_	_
13-11	1992-1993	,	_	_	_	_
13-12	1994-1997	the	object[103]	giv[103]	ana	13-20[0_103]
13-13	1998-2001	S-S	place|object[103]	new|giv[103]	_	_
13-14	2002-2008	bridge	object[103]	giv[103]	_	_
13-15	2009-2016	between	object[103]	giv[103]	_	_
13-16	2017-2021	DmxA	object[103]|abstract|organization[106]	giv[103]|giv|new[106]	coref	15-8
13-17	2022-2024	wt	object[103]|person|organization[106]	giv[103]|giv|new[106]	_	_
13-18	2025-2030	units	object[103]|organization[106]	giv[103]|new[106]	_	_
13-19	2031-2033	in	object[103]|organization[106]	giv[103]|new[106]	_	_
13-20	2034-2037	its	object[103]|organization[106]|object|abstract[108]	giv[103]|new[106]|giv|new[108]	coref	14-12[119_0]
13-21	2038-2045	dimeric	object[103]|organization[106]|abstract[108]	giv[103]|new[106]|new[108]	_	_
13-22	2046-2050	form	object[103]|organization[106]|abstract[108]	giv[103]|new[106]|new[108]	_	_
13-23	2051-2054	did	_	_	_	_
13-24	2055-2058	not	_	_	_	_
13-25	2059-2063	have	_	_	_	_
13-26	2064-2067	any	abstract[109]	new[109]	coref	21-32[182_109]
13-27	2068-2074	effect	abstract[109]	new[109]	_	_
13-28	2075-2077	on	abstract[109]	new[109]	_	_
13-29	2078-2081	the	abstract[109]|abstract[110]|abstract[111]	new[109]|giv[110]|new[111]	coref	32-19[282_111]
13-30	2082-2091	stability	abstract[109]|abstract[110]|abstract[111]	new[109]|giv[110]|new[111]	_	_
13-31	2092-2094	or	abstract[109]|abstract[111]	new[109]|new[111]	_	_
13-32	2095-2098	the	abstract[109]|abstract[111]|abstract[112]	new[109]|new[111]|new[112]	coref	32-22[283_112]
13-33	2099-2107	activity	abstract[109]|abstract[111]|abstract[112]	new[109]|new[111]|new[112]	_	_
13-34	2108-2110	of	abstract[109]|abstract[111]|abstract[112]	new[109]|new[111]|new[112]	_	_
13-35	2111-2114	the	abstract[109]|abstract[111]|abstract[112]|substance[113]	new[109]|new[111]|new[112]|giv[113]	coref	14-27[123_113]
13-36	2115-2121	enzyme	abstract[109]|abstract[111]|abstract[112]|substance[113]	new[109]|new[111]|new[112]|giv[113]	_	_
13-37	2122-2123	.	_	_	_	_

#Text=Furthermore , our experiments revealed that the presence or absence of such cysteine bridge neither influenced any of the catalytic properties nor the storage stability of the enzyme .
14-1	2124-2135	Furthermore	_	_	_	_
14-2	2136-2137	,	_	_	_	_
14-3	2138-2141	our	person|event[115]	acc|new[115]	ana	24-2
14-4	2142-2153	experiments	event[115]	new[115]	_	_
14-5	2154-2162	revealed	_	_	_	_
14-6	2163-2167	that	_	_	_	_
14-7	2168-2171	the	abstract[116]	giv[116]	_	_
14-8	2172-2180	presence	abstract[116]	giv[116]	_	_
14-9	2181-2183	or	_	_	_	_
14-10	2184-2191	absence	abstract[117]	new[117]	_	_
14-11	2192-2194	of	abstract[117]	new[117]	_	_
14-12	2195-2199	such	abstract[117]|object[119]	new[117]|giv[119]	coref	16-3[133_119]
14-13	2200-2208	cysteine	abstract[117]|place|object[119]	new[117]|giv|giv[119]	_	_
14-14	2209-2215	bridge	abstract[117]|object[119]	new[117]|giv[119]	_	_
14-15	2216-2223	neither	_	_	_	_
14-16	2224-2234	influenced	_	_	_	_
14-17	2235-2238	any	_	_	_	_
14-18	2239-2241	of	_	_	_	_
14-19	2242-2245	the	abstract[120]	new[120]	_	_
14-20	2246-2255	catalytic	abstract[120]	new[120]	_	_
14-21	2256-2266	properties	abstract[120]	new[120]	_	_
14-22	2267-2270	nor	_	_	_	_
14-23	2271-2274	the	abstract[122]	new[122]	ana	15-1[0_122]
14-24	2275-2282	storage	place|abstract[122]	new|new[122]	_	_
14-25	2283-2292	stability	abstract[122]	new[122]	_	_
14-26	2293-2295	of	abstract[122]	new[122]	_	_
14-27	2296-2299	the	abstract[122]|substance[123]	new[122]|giv[123]	coref	15-22[129_123]
14-28	2300-2306	enzyme	abstract[122]|substance[123]	new[122]|giv[123]	_	_
14-29	2307-2308	.	_	_	_	_

#Text=It is also worth mentioning that the DmxA wt oligomer equilibrium varies in solution , and only a small part of the enzyme ( up to 30 % ) is present as a dimer .
15-1	2309-2311	It	abstract	giv	_	_
15-2	2312-2314	is	_	_	_	_
15-3	2315-2319	also	_	_	_	_
15-4	2320-2325	worth	_	_	_	_
15-5	2326-2336	mentioning	_	_	_	_
15-6	2337-2341	that	_	_	_	_
15-7	2342-2345	the	abstract[127]	new[127]	_	_
15-8	2346-2350	DmxA	abstract|abstract[127]	giv|new[127]	coref	17-12
15-9	2351-2353	wt	abstract[127]	new[127]	_	_
15-10	2354-2362	oligomer	person|abstract[127]	new|new[127]	_	_
15-11	2363-2374	equilibrium	abstract[127]	new[127]	_	_
15-12	2375-2381	varies	_	_	_	_
15-13	2382-2384	in	_	_	_	_
15-14	2385-2393	solution	substance	new	_	_
15-15	2394-2395	,	_	_	_	_
15-16	2396-2399	and	_	_	_	_
15-17	2400-2404	only	_	_	_	_
15-18	2405-2406	a	_	_	_	_
15-19	2407-2412	small	_	_	_	_
15-20	2413-2417	part	_	_	_	_
15-21	2418-2420	of	_	_	_	_
15-22	2421-2424	the	substance[129]	giv[129]	coref	16-14[135_129]
15-23	2425-2431	enzyme	substance[129]	giv[129]	_	_
15-24	2432-2433	(	_	_	_	_
15-25	2434-2436	up	abstract[130]	new[130]	_	_
15-26	2437-2439	to	abstract[130]	new[130]	_	_
15-27	2440-2442	30	abstract[130]	new[130]	_	_
15-28	2443-2444	%	abstract[130]	new[130]	_	_
15-29	2445-2446	)	_	_	_	_
15-30	2447-2449	is	_	_	_	_
15-31	2450-2457	present	_	_	_	_
15-32	2458-2460	as	_	_	_	_
15-33	2461-2462	a	abstract[131]	giv[131]	_	_
15-34	2463-2468	dimer	abstract[131]	giv[131]	_	_
15-35	2469-2470	.	_	_	_	_

#Text=Therefore , the disulfide bridge does not contribute to the overall stability of the enzyme .
16-1	2471-2480	Therefore	_	_	_	_
16-2	2481-2482	,	_	_	_	_
16-3	2483-2486	the	object[133]	giv[133]	_	_
16-4	2487-2496	disulfide	place|object[133]	giv|giv[133]	_	_
16-5	2497-2503	bridge	object[133]	giv[133]	_	_
16-6	2504-2508	does	_	_	_	_
16-7	2509-2512	not	_	_	_	_
16-8	2513-2523	contribute	_	_	_	_
16-9	2524-2526	to	_	_	_	_
16-10	2527-2530	the	abstract[134]	new[134]	coref	19-11[157_134]
16-11	2531-2538	overall	abstract[134]	new[134]	_	_
16-12	2539-2548	stability	abstract[134]	new[134]	_	_
16-13	2549-2551	of	abstract[134]	new[134]	_	_
16-14	2552-2555	the	abstract[134]|substance[135]	new[134]|giv[135]	coref	19-11[0_135]
16-15	2556-2562	enzyme	abstract[134]|substance[135]	new[134]|giv[135]	_	_
16-16	2563-2564	.	_	_	_	_

#Text=A unique composition of the catalytic pentad was observed both in DmxA wt sequence and crystal structure , containing a glutamine instead of the typical asparagine present in other members of the subfamily HLD-II .
17-1	2565-2566	A	abstract[136]	new[136]	_	_
17-2	2567-2573	unique	abstract[136]	new[136]	_	_
17-3	2574-2585	composition	abstract[136]	new[136]	_	_
17-4	2586-2588	of	abstract[136]	new[136]	_	_
17-5	2589-2592	the	abstract[136]|object[137]	new[136]|new[137]	_	_
17-6	2593-2602	catalytic	abstract[136]|object[137]	new[136]|new[137]	_	_
17-7	2603-2609	pentad	abstract[136]|object[137]	new[136]|new[137]	_	_
17-8	2610-2613	was	_	_	_	_
17-9	2614-2622	observed	_	_	_	_
17-10	2623-2627	both	abstract[140]	new[140]	_	_
17-11	2628-2630	in	abstract[140]	new[140]	_	_
17-12	2631-2635	DmxA	abstract|abstract[140]	giv|new[140]	coref	20-9
17-13	2636-2638	wt	abstract|abstract[140]	giv|new[140]	_	_
17-14	2639-2647	sequence	abstract[140]	new[140]	_	_
17-15	2648-2651	and	_	_	_	_
17-16	2652-2659	crystal	place|abstract[142]	new|giv[142]	coref	20-9[166_142]
17-17	2660-2669	structure	abstract[142]	giv[142]	_	_
17-18	2670-2671	,	_	_	_	_
17-19	2672-2682	containing	_	_	_	_
17-20	2683-2684	a	substance[143]	new[143]	coref	21-3[170_143]
17-21	2685-2694	glutamine	substance[143]	new[143]	_	_
17-22	2695-2702	instead	substance[143]	new[143]	_	_
17-23	2703-2705	of	substance[143]	new[143]	_	_
17-24	2706-2709	the	substance[143]|substance[144]	new[143]|new[144]	coref	21-6[0_144]
17-25	2710-2717	typical	substance[143]|substance[144]	new[143]|new[144]	_	_
17-26	2718-2728	asparagine	substance[143]|substance[144]	new[143]|new[144]	_	_
17-27	2729-2736	present	substance[143]|substance[144]	new[143]|new[144]	_	_
17-28	2737-2739	in	substance[143]|substance[144]	new[143]|new[144]	_	_
17-29	2740-2745	other	substance[143]|substance[144]|person[145]	new[143]|new[144]|giv[145]	_	_
17-30	2746-2753	members	substance[143]|substance[144]|person[145]	new[143]|new[144]|giv[145]	_	_
17-31	2754-2756	of	substance[143]|substance[144]|person[145]	new[143]|new[144]|giv[145]	_	_
17-32	2757-2760	the	substance[143]|substance[144]|person[145]|animal[146]	new[143]|new[144]|giv[145]|giv[146]	_	_
17-33	2761-2770	subfamily	substance[143]|substance[144]|person[145]|animal[146]	new[143]|new[144]|giv[145]|giv[146]	_	_
17-34	2771-2777	HLD-II	substance[143]|substance[144]|person[145]|abstract	new[143]|new[144]|giv[145]|giv	_	_
17-35	2778-2779	.	_	_	_	_

#Text=Another HLD with an unusual halide-stabilizing residue ( DatA containing tyrosine instead of tryptophan ) was described earlier .
18-1	2780-2787	Another	abstract[148]	giv[148]	_	_
18-2	2788-2791	HLD	abstract[148]	giv[148]	_	_
18-3	2792-2796	with	abstract[148]	giv[148]	_	_
18-4	2797-2799	an	abstract[148]|object[149]	giv[148]|new[149]	coref	19-5[155_149]
18-5	2800-2807	unusual	abstract[148]|object[149]	giv[148]|new[149]	_	_
18-6	2808-2826	halide-stabilizing	abstract[148]|object[149]	giv[148]|new[149]	_	_
18-7	2827-2834	residue	abstract[148]|object[149]	giv[148]|new[149]	_	_
18-8	2835-2836	(	_	_	_	_
18-9	2837-2841	DatA	object	new	_	_
18-10	2842-2852	containing	_	_	_	_
18-11	2853-2861	tyrosine	substance	new	_	_
18-12	2862-2869	instead	_	_	_	_
18-13	2870-2872	of	_	_	_	_
18-14	2873-2883	tryptophan	person	new	_	_
18-15	2884-2885	)	_	_	_	_
18-16	2886-2889	was	_	_	_	_
18-17	2890-2899	described	_	_	_	_
18-18	2900-2907	earlier	_	_	_	_
18-19	2908-2909	.	_	_	_	_

#Text=In this case , the unique halide stabilizing residue decreased enzyme stability ( by 3.5 ° C ) and only moderately affected enzyme specificity .
19-1	2910-2912	In	_	_	_	_
19-2	2913-2917	this	object[153]	new[153]	coref	24-2[202_153]
19-3	2918-2922	case	object[153]	new[153]	_	_
19-4	2923-2924	,	_	_	_	_
19-5	2925-2928	the	object[155]	giv[155]	coref	20-16[169_155]
19-6	2929-2935	unique	object[155]	giv[155]	_	_
19-7	2936-2942	halide	substance|object[155]	new|giv[155]	_	_
19-8	2943-2954	stabilizing	object[155]	giv[155]	_	_
19-9	2955-2962	residue	object[155]	giv[155]	_	_
19-10	2963-2972	decreased	_	_	_	_
19-11	2973-2979	enzyme	substance|abstract[157]	giv|giv[157]	coref	19-23
19-12	2980-2989	stability	abstract[157]	giv[157]	_	_
19-13	2990-2991	(	_	_	_	_
19-14	2992-2994	by	_	_	_	_
19-15	2995-2998	3.5	abstract[158]	new[158]	_	_
19-16	2999-3000	°	abstract[158]	new[158]	_	_
19-17	3001-3002	C	abstract[158]	new[158]	_	_
19-18	3003-3004	)	_	_	_	_
19-19	3005-3008	and	_	_	_	_
19-20	3009-3013	only	_	_	_	_
19-21	3014-3024	moderately	_	_	_	_
19-22	3025-3033	affected	_	_	_	_
19-23	3034-3040	enzyme	substance|abstract[160]	giv|new[160]	coref|coref	21-12[174_0]|22-7[189_160]
19-24	3041-3052	specificity	abstract[160]	new[160]	_	_
19-25	3053-3054	.	_	_	_	_

#Text=The position of the Q40 side chain in DmxA wt structure disables its functioning as a halide-stabilizing residue .
20-1	3055-3058	The	abstract[161]	new[161]	_	_
20-2	3059-3067	position	abstract[161]	new[161]	_	_
20-3	3068-3070	of	abstract[161]	new[161]	_	_
20-4	3071-3074	the	abstract[161]|object[164]	new[161]|new[164]	ana	20-13[0_164]
20-5	3075-3078	Q40	abstract[161]|substance|object[164]	new[161]|new|new[164]	_	_
20-6	3079-3083	side	abstract[161]|place|object[164]	new[161]|new|new[164]	_	_
20-7	3084-3089	chain	abstract[161]|object[164]	new[161]|new[164]	_	_
20-8	3090-3092	in	abstract[161]	new[161]	_	_
20-9	3093-3097	DmxA	abstract[161]|abstract|abstract[166]	new[161]|giv|giv[166]	coref|coref	22-18|25-5[210_166]
20-10	3098-3100	wt	abstract[161]|abstract[166]	new[161]|giv[166]	_	_
20-11	3101-3110	structure	abstract[161]|abstract[166]	new[161]|giv[166]	_	_
20-12	3111-3119	disables	_	_	_	_
20-13	3120-3123	its	object|abstract[168]	giv|new[168]	_	_
20-14	3124-3135	functioning	abstract[168]	new[168]	_	_
20-15	3136-3138	as	abstract[168]	new[168]	_	_
20-16	3139-3140	a	abstract[168]|object[169]	new[168]|giv[169]	_	_
20-17	3141-3159	halide-stabilizing	abstract[168]|object[169]	new[168]|giv[169]	_	_
20-18	3160-3167	residue	abstract[168]|object[169]	new[168]|giv[169]	_	_
20-19	3168-3169	.	_	_	_	_

#Text=When replacing the glutamine with asparagine , the melting temperature of the enzyme decreased by 2 ° C ( T m , app = 63.9 ± 0.2 ° C ) confirming a small stabilizing effect of glutamine interactions in the protein core .
21-1	3170-3174	When	_	_	_	_
21-2	3175-3184	replacing	_	_	_	_
21-3	3185-3188	the	substance[170]	giv[170]	coref	21-37[0_170]
21-4	3189-3198	glutamine	substance[170]	giv[170]	_	_
21-5	3199-3203	with	_	_	_	_
21-6	3204-3214	asparagine	substance	giv	coref	32-6
21-7	3215-3216	,	_	_	_	_
21-8	3217-3220	the	abstract[173]	giv[173]	coref	28-17[244_173]
21-9	3221-3228	melting	event|abstract[173]	giv|giv[173]	coref	28-20
21-10	3229-3240	temperature	abstract[173]	giv[173]	_	_
21-11	3241-3243	of	abstract[173]	giv[173]	_	_
21-12	3244-3247	the	abstract[173]|substance[174]	giv[173]|giv[174]	coref	24-13[0_174]
21-13	3248-3254	enzyme	abstract[173]|substance[174]	giv[173]|giv[174]	_	_
21-14	3255-3264	decreased	_	_	_	_
21-15	3265-3267	by	_	_	_	_
21-16	3268-3269	2	abstract[175]	new[175]	_	_
21-17	3270-3271	°	abstract[175]	new[175]	_	_
21-18	3272-3273	C	abstract[175]|person	new[175]|new	coref	21-29
21-19	3274-3275	(	_	_	_	_
21-20	3276-3277	T	person|abstract[178]	giv|giv[178]	appos	21-23[0_178]
21-21	3278-3279	m	abstract[178]	giv[178]	_	_
21-22	3280-3281	,	_	_	_	_
21-23	3282-3285	app	abstract	giv	_	_
21-24	3286-3287	=	_	_	_	_
21-25	3288-3292	63.9	abstract[180]	new[180]	_	_
21-26	3293-3294	±	abstract[180]	new[180]	_	_
21-27	3295-3298	0.2	abstract[180]	new[180]	_	_
21-28	3299-3300	°	abstract[180]	new[180]	_	_
21-29	3301-3302	C	abstract[180]|person	new[180]|giv	_	_
21-30	3303-3304	)	_	_	_	_
21-31	3305-3315	confirming	_	_	_	_
21-32	3316-3317	a	abstract[182]	giv[182]	_	_
21-33	3318-3323	small	abstract[182]	giv[182]	_	_
21-34	3324-3335	stabilizing	abstract[182]	giv[182]	_	_
21-35	3336-3342	effect	abstract[182]	giv[182]	_	_
21-36	3343-3345	of	abstract[182]	giv[182]	_	_
21-37	3346-3355	glutamine	abstract[182]|substance|event[184]	giv[182]|giv|giv[184]	coref|coref	26-23[225_184]|32-4
21-38	3356-3368	interactions	abstract[182]|event[184]	giv[182]|giv[184]	_	_
21-39	3369-3371	in	abstract[182]|event[184]	giv[182]|giv[184]	_	_
21-40	3372-3375	the	abstract[182]|event[184]|object[186]	giv[182]|giv[184]|new[186]	coref	28-7[240_186]
21-41	3376-3383	protein	abstract[182]|event[184]|substance|object[186]	giv[182]|giv[184]|giv|new[186]	coref	23-17
21-42	3384-3388	core	abstract[182]|event[184]|object[186]	giv[182]|giv[184]|new[186]	_	_
21-43	3389-3390	.	_	_	_	_

#Text=Moreover , an interesting shift in substrate specificity from SSG-I to SSG-IV was observed on the variant DmxA Q/N .
22-1	3391-3399	Moreover	_	_	_	_
22-2	3400-3401	,	_	_	_	_
22-3	3402-3404	an	event[187]	new[187]	_	_
22-4	3405-3416	interesting	event[187]	new[187]	_	_
22-5	3417-3422	shift	event[187]	new[187]	_	_
22-6	3423-3425	in	event[187]	new[187]	_	_
22-7	3426-3435	substrate	event[187]|substance|abstract[189]	new[187]|new|giv[189]	coref|coref	23-5|23-4[197_189]
22-8	3436-3447	specificity	event[187]|abstract[189]	new[187]|giv[189]	_	_
22-9	3448-3452	from	event[187]	new[187]	_	_
22-10	3453-3458	SSG-I	event[187]|abstract	new[187]|new	_	_
22-11	3459-3461	to	event[187]	new[187]	_	_
22-12	3462-3468	SSG-IV	event[187]|abstract	new[187]|new	_	_
22-13	3469-3472	was	_	_	_	_
22-14	3473-3481	observed	_	_	_	_
22-15	3482-3484	on	_	_	_	_
22-16	3485-3488	the	abstract[194]	new[194]	coref	34-9[298_194]
22-17	3489-3496	variant	abstract|abstract[194]	new|new[194]	_	_
22-18	3497-3501	DmxA	abstract|abstract[194]	giv|new[194]	coref	25-5
22-19	3502-3505	Q/N	abstract[194]	new[194]	_	_
22-20	3506-3507	.	_	_	_	_

#Text=Such changes in the substrate specificity in HLDs are normally only be achieved after a sophisticated protein engineering .
23-1	3508-3512	Such	abstract[195]	new[195]	_	_
23-2	3513-3520	changes	abstract[195]	new[195]	_	_
23-3	3521-3523	in	abstract[195]	new[195]	_	_
23-4	3524-3527	the	abstract[195]|abstract[197]	new[195]|giv[197]	coref	24-14[206_197]
23-5	3528-3537	substrate	abstract[195]|substance|abstract[197]	new[195]|giv|giv[197]	coref	24-14
23-6	3538-3549	specificity	abstract[195]|abstract[197]	new[195]|giv[197]	_	_
23-7	3550-3552	in	abstract[195]	new[195]	_	_
23-8	3553-3557	HLDs	abstract[195]|abstract	new[195]|giv	coref	33-29[291_0]
23-9	3558-3561	are	_	_	_	_
23-10	3562-3570	normally	_	_	_	_
23-11	3571-3575	only	_	_	_	_
23-12	3576-3578	be	_	_	_	_
23-13	3579-3587	achieved	_	_	_	_
23-14	3588-3593	after	_	_	_	_
23-15	3594-3595	a	abstract[200]	new[200]	coref	29-1[245_200]
23-16	3596-3609	sophisticated	abstract[200]	new[200]	_	_
23-17	3610-3617	protein	substance|abstract[200]	giv|new[200]	coref	26-20
23-18	3618-3629	engineering	abstract[200]	new[200]	_	_
23-19	3630-3631	.	_	_	_	_

#Text=In our case , a single mutation was sufficient to shift the enzyme substrate specificity group .
24-1	3632-3634	In	_	_	_	_
24-2	3635-3638	our	person|object[202]	giv|giv[202]	ana	30-5
24-3	3639-3643	case	object[202]	giv[202]	_	_
24-4	3644-3645	,	_	_	_	_
24-5	3646-3647	a	abstract[203]	new[203]	_	_
24-6	3648-3654	single	abstract[203]	new[203]	_	_
24-7	3655-3663	mutation	abstract[203]	new[203]	_	_
24-8	3664-3667	was	_	_	_	_
24-9	3668-3678	sufficient	_	_	_	_
24-10	3679-3681	to	_	_	_	_
24-11	3682-3687	shift	_	_	_	_
24-12	3688-3691	the	abstract[207]	new[207]	_	_
24-13	3692-3698	enzyme	substance|abstract[207]	giv|new[207]	coref	25-16
24-14	3699-3708	substrate	substance|abstract[206]|abstract[207]	giv|giv[206]|new[207]	_	_
24-15	3709-3720	specificity	abstract[206]|abstract[207]	giv[206]|new[207]	_	_
24-16	3721-3726	group	abstract[207]	new[207]	_	_
24-17	3727-3728	.	_	_	_	_

#Text=A deeper analysis of DmxA wt structure revealed an unusually small hydrophobic pocket containing the enzyme active site connected with the surrounding solvent by very narrow and closed tunnels .
25-1	3729-3730	A	abstract[208]	new[208]	_	_
25-2	3731-3737	deeper	abstract[208]	new[208]	_	_
25-3	3738-3746	analysis	abstract[208]	new[208]	_	_
25-4	3747-3749	of	abstract[208]	new[208]	_	_
25-5	3750-3754	DmxA	abstract[208]|abstract|abstract[210]	new[208]|giv|giv[210]	coref|coref	27-18[233_210]|30-19
25-6	3755-3757	wt	abstract[208]|abstract[210]	new[208]|giv[210]	_	_
25-7	3758-3767	structure	abstract[208]|abstract[210]	new[208]|giv[210]	_	_
25-8	3768-3776	revealed	_	_	_	_
25-9	3777-3779	an	object[211]	new[211]	_	_
25-10	3780-3789	unusually	object[211]	new[211]	_	_
25-11	3790-3795	small	object[211]	new[211]	_	_
25-12	3796-3807	hydrophobic	object[211]	new[211]	_	_
25-13	3808-3814	pocket	object[211]	new[211]	_	_
25-14	3815-3825	containing	object[211]	new[211]	_	_
25-15	3826-3829	the	object[211]|place[213]	new[211]|new[213]	coref	29-6[248_213]
25-16	3830-3836	enzyme	object[211]|substance|place[213]	new[211]|giv|new[213]	coref	28-18
25-17	3837-3843	active	object[211]|place[213]	new[211]|new[213]	_	_
25-18	3844-3848	site	object[211]|place[213]	new[211]|new[213]	_	_
25-19	3849-3858	connected	object[211]	new[211]	_	_
25-20	3859-3863	with	object[211]	new[211]	_	_
25-21	3864-3867	the	object[211]|substance[214]	new[211]|new[214]	coref	29-11[249_214]
25-22	3868-3879	surrounding	object[211]|substance[214]	new[211]|new[214]	_	_
25-23	3880-3887	solvent	object[211]|substance[214]	new[211]|new[214]	_	_
25-24	3888-3890	by	object[211]	new[211]	_	_
25-25	3891-3895	very	object[211]|object[215]	new[211]|new[215]	coref	29-3[246_215]
25-26	3896-3902	narrow	object[211]|object[215]	new[211]|new[215]	_	_
25-27	3903-3906	and	object[211]|object[215]	new[211]|new[215]	_	_
25-28	3907-3913	closed	object[211]|object[215]	new[211]|new[215]	_	_
25-29	3914-3921	tunnels	object[211]|object[215]	new[211]|new[215]	_	_
25-30	3922-3923	.	_	_	_	_

#Text=The presence of phenylalanine and methionine as bottleneck residues was not overly surprising since they often provide stabilization of protein structures via hydrophobic interactions .
26-1	3924-3927	The	abstract[216]	new[216]	_	_
26-2	3928-3936	presence	abstract[216]	new[216]	_	_
26-3	3937-3939	of	abstract[216]	new[216]	_	_
26-4	3940-3953	phenylalanine	abstract[216]|substance	new[216]|new	_	_
26-5	3954-3957	and	abstract[216]	new[216]	_	_
26-6	3958-3968	methionine	abstract[216]|substance	new[216]|new	_	_
26-7	3969-3971	as	abstract[216]	new[216]	_	_
26-8	3972-3982	bottleneck	abstract[216]|object|object[220]	new[216]|new|new[220]	ana|coref	26-15[0_220]|27-26
26-9	3983-3991	residues	abstract[216]|object[220]	new[216]|new[220]	_	_
26-10	3992-3995	was	_	_	_	_
26-11	3996-3999	not	_	_	_	_
26-12	4000-4006	overly	_	_	_	_
26-13	4007-4017	surprising	_	_	_	_
26-14	4018-4023	since	_	_	_	_
26-15	4024-4028	they	object	giv	coref	27-3[227_0]
26-16	4029-4034	often	_	_	_	_
26-17	4035-4042	provide	_	_	_	_
26-18	4043-4056	stabilization	abstract[222]	new[222]	_	_
26-19	4057-4059	of	abstract[222]	new[222]	_	_
26-20	4060-4067	protein	abstract[222]|substance|abstract[224]	new[222]|giv|giv[224]	coref	28-8
26-21	4068-4078	structures	abstract[222]|abstract[224]	new[222]|giv[224]	_	_
26-22	4079-4082	via	_	_	_	_
26-23	4083-4094	hydrophobic	event[225]	giv[225]	coref	27-22[234_225]
26-24	4095-4107	interactions	event[225]	giv[225]	_	_
26-25	4108-4109	.	_	_	_	_

#Text=Replacement of bulky residues with alanines in the main tunnel opened the tunnel and suppressed stabilization of the tunnel structure via interactions provided by the bottleneck residues .
27-1	4110-4121	Replacement	event[226]	new[226]	_	_
27-2	4122-4124	of	event[226]	new[226]	_	_
27-3	4125-4130	bulky	event[226]|object[227]	new[226]|giv[227]	coref	27-25[236_227]
27-4	4131-4139	residues	event[226]|object[227]	new[226]|giv[227]	_	_
27-5	4140-4144	with	event[226]	new[226]	_	_
27-6	4145-4153	alanines	event[226]|substance	new[226]|new	_	_
27-7	4154-4156	in	event[226]	new[226]	_	_
27-8	4157-4160	the	event[226]|place[229]	new[226]|new[229]	coref	10-6[0_229]
27-9	4161-4165	main	event[226]|place[229]	new[226]|new[229]	_	_
27-10	4166-4172	tunnel	event[226]|place[229]	new[226]|new[229]	_	_
27-11	4173-4179	opened	_	_	_	_
27-12	4180-4183	the	place[230]	giv[230]	coref	27-19
27-13	4184-4190	tunnel	place[230]	giv[230]	_	_
27-14	4191-4194	and	_	_	_	_
27-15	4195-4205	suppressed	_	_	_	_
27-16	4206-4219	stabilization	abstract[231]	new[231]	coref	29-23[252_231]
27-17	4220-4222	of	abstract[231]	new[231]	_	_
27-18	4223-4226	the	abstract[231]|abstract[233]	new[231]|giv[233]	_	_
27-19	4227-4233	tunnel	abstract[231]|place|abstract[233]	new[231]|giv|giv[233]	ana	28-1
27-20	4234-4243	structure	abstract[231]|abstract[233]	new[231]|giv[233]	_	_
27-21	4244-4247	via	_	_	_	_
27-22	4248-4260	interactions	event[234]	giv[234]	coref	30-28[0_234]
27-23	4261-4269	provided	event[234]	giv[234]	_	_
27-24	4270-4272	by	event[234]	giv[234]	_	_
27-25	4273-4276	the	event[234]|object[236]	giv[234]|giv[236]	_	_
27-26	4277-4287	bottleneck	event[234]|object|object[236]	giv[234]|giv|giv[236]	_	_
27-27	4288-4296	residues	event[234]|object[236]	giv[234]|giv[236]	_	_
27-28	4297-4298	.	_	_	_	_

#Text=This led to the destabilization of the protein core represented by 9 ° C decrease of the enzyme apparent melting temperature .
28-1	4299-4303	This	place	giv	coref	32-10[279_0]
28-2	4304-4307	led	_	_	_	_
28-3	4308-4310	to	_	_	_	_
28-4	4311-4314	the	abstract[238]	new[238]	_	_
28-5	4315-4330	destabilization	abstract[238]	new[238]	_	_
28-6	4331-4333	of	abstract[238]	new[238]	_	_
28-7	4334-4337	the	abstract[238]|object[240]	new[238]|giv[240]	_	_
28-8	4338-4345	protein	abstract[238]|substance|object[240]	new[238]|giv|giv[240]	_	_
28-9	4346-4350	core	abstract[238]|object[240]	new[238]|giv[240]	_	_
28-10	4351-4362	represented	abstract[238]|object[240]	new[238]|giv[240]	_	_
28-11	4363-4365	by	abstract[238]|object[240]	new[238]|giv[240]	_	_
28-12	4366-4367	9	abstract[238]|object[240]|event[241]	new[238]|giv[240]|new[241]	_	_
28-13	4368-4369	°	abstract[238]|object[240]|event[241]	new[238]|giv[240]|new[241]	_	_
28-14	4370-4371	C	abstract[238]|object[240]|event[241]	new[238]|giv[240]|new[241]	_	_
28-15	4372-4380	decrease	abstract[238]|object[240]|event[241]	new[238]|giv[240]|new[241]	_	_
28-16	4381-4383	of	abstract[238]|object[240]|event[241]	new[238]|giv[240]|new[241]	_	_
28-17	4384-4387	the	abstract[238]|object[240]|event[241]|abstract[244]	new[238]|giv[240]|new[241]|giv[244]	coref	33-22[289_244]
28-18	4388-4394	enzyme	abstract[238]|object[240]|event[241]|substance|abstract[244]	new[238]|giv[240]|new[241]|giv|giv[244]	coref	29-7
28-19	4395-4403	apparent	abstract[238]|object[240]|event[241]|abstract[244]	new[238]|giv[240]|new[241]|giv[244]	_	_
28-20	4404-4411	melting	abstract[238]|object[240]|event[241]|event|abstract[244]	new[238]|giv[240]|new[241]|giv|giv[244]	coref	33-23
28-21	4412-4423	temperature	abstract[238]|object[240]|event[241]|abstract[244]	new[238]|giv[240]|new[241]|giv[244]	_	_
28-22	4424-4425	.	_	_	_	_

#Text=Engineering of the tunnels connecting buried enzyme active site with the surrounding solvent has previously been described as a powerful strategy for enzyme stabilization .
29-1	4426-4437	Engineering	abstract[245]	giv[245]	_	_
29-2	4438-4440	of	abstract[245]	giv[245]	_	_
29-3	4441-4444	the	abstract[245]|object[246]	giv[245]|giv[246]	coref	30-8[255_246]
29-4	4445-4452	tunnels	abstract[245]|object[246]	giv[245]|giv[246]	_	_
29-5	4453-4463	connecting	abstract[245]|object[246]	giv[245]|giv[246]	_	_
29-6	4464-4470	buried	abstract[245]|object[246]|place[248]	giv[245]|giv[246]|giv[248]	_	_
29-7	4471-4477	enzyme	abstract[245]|object[246]|substance|place[248]	giv[245]|giv[246]|giv|giv[248]	coref	29-23
29-8	4478-4484	active	abstract[245]|object[246]|place[248]	giv[245]|giv[246]|giv[248]	_	_
29-9	4485-4489	site	abstract[245]|object[246]|place[248]	giv[245]|giv[246]|giv[248]	_	_
29-10	4490-4494	with	abstract[245]|object[246]	giv[245]|giv[246]	_	_
29-11	4495-4498	the	abstract[245]|object[246]|substance[249]	giv[245]|giv[246]|giv[249]	_	_
29-12	4499-4510	surrounding	abstract[245]|object[246]|substance[249]	giv[245]|giv[246]|giv[249]	_	_
29-13	4511-4518	solvent	abstract[245]|object[246]|substance[249]	giv[245]|giv[246]|giv[249]	_	_
29-14	4519-4522	has	_	_	_	_
29-15	4523-4533	previously	_	_	_	_
29-16	4534-4538	been	_	_	_	_
29-17	4539-4548	described	_	_	_	_
29-18	4549-4551	as	_	_	_	_
29-19	4552-4553	a	abstract[250]	new[250]	_	_
29-20	4554-4562	powerful	abstract[250]	new[250]	_	_
29-21	4563-4571	strategy	abstract[250]	new[250]	_	_
29-22	4572-4575	for	abstract[250]	new[250]	_	_
29-23	4576-4582	enzyme	abstract[250]|substance|abstract[252]	new[250]|giv|giv[252]	coref|coref	30-43[264_0]|31-29[274_252]
29-24	4583-4596	stabilization	abstract[250]|abstract[252]	new[250]|giv[252]	_	_
29-25	4597-4598	.	_	_	_	_

#Text=In this study , we proved that narrow tunnels play a crucial role in the paradoxical stability of DmxA due to multiple van der Waals and hydrophobic interactions , although they are not the only factor responsible for the unique properties of the enzyme .
30-1	4599-4601	In	_	_	_	_
30-2	4602-4606	this	abstract[253]	new[253]	_	_
30-3	4607-4612	study	abstract[253]	new[253]	_	_
30-4	4613-4614	,	_	_	_	_
30-5	4615-4617	we	person	giv	ana	31-14
30-6	4618-4624	proved	_	_	_	_
30-7	4625-4629	that	_	_	_	_
30-8	4630-4636	narrow	object[255]	giv[255]	_	_
30-9	4637-4644	tunnels	object[255]	giv[255]	_	_
30-10	4645-4649	play	_	_	_	_
30-11	4650-4651	a	abstract[256]	new[256]	_	_
30-12	4652-4659	crucial	abstract[256]	new[256]	_	_
30-13	4660-4664	role	abstract[256]	new[256]	_	_
30-14	4665-4667	in	abstract[256]	new[256]	_	_
30-15	4668-4671	the	abstract[256]|abstract[257]	new[256]|new[257]	_	_
30-16	4672-4683	paradoxical	abstract[256]|abstract[257]	new[256]|new[257]	_	_
30-17	4684-4693	stability	abstract[256]|abstract[257]	new[256]|new[257]	_	_
30-18	4694-4696	of	abstract[256]|abstract[257]	new[256]|new[257]	_	_
30-19	4697-4701	DmxA	abstract[256]|abstract[257]|abstract	new[256]|new[257]|giv	coref	31-11
30-20	4702-4705	due	abstract[256]|abstract[257]	new[256]|new[257]	_	_
30-21	4706-4708	to	abstract[256]|abstract[257]	new[256]|new[257]	_	_
30-22	4709-4717	multiple	abstract[256]|abstract[257]|person[259]	new[256]|new[257]|new[259]	_	_
30-23	4718-4721	van	abstract[256]|abstract[257]|person[259]	new[256]|new[257]|new[259]	_	_
30-24	4722-4725	der	abstract[256]|abstract[257]|person[259]	new[256]|new[257]|new[259]	_	_
30-25	4726-4731	Waals	abstract[256]|abstract[257]|person[259]	new[256]|new[257]|new[259]	_	_
30-26	4732-4735	and	abstract[256]|abstract[257]	new[256]|new[257]	_	_
30-27	4736-4747	hydrophobic	abstract[256]|abstract[257]	new[256]|new[257]	_	_
30-28	4748-4760	interactions	abstract[256]|abstract[257]|event	new[256]|new[257]|giv	ana	30-31
30-29	4761-4762	,	_	_	_	_
30-30	4763-4771	although	_	_	_	_
30-31	4772-4776	they	event	giv	_	_
30-32	4777-4780	are	_	_	_	_
30-33	4781-4784	not	_	_	_	_
30-34	4785-4788	the	abstract[262]	new[262]	_	_
30-35	4789-4793	only	abstract[262]	new[262]	_	_
30-36	4794-4800	factor	abstract[262]	new[262]	_	_
30-37	4801-4812	responsible	abstract[262]	new[262]	_	_
30-38	4813-4816	for	abstract[262]	new[262]	_	_
30-39	4817-4820	the	abstract[262]|abstract[263]	new[262]|new[263]	_	_
30-40	4821-4827	unique	abstract[262]|abstract[263]	new[262]|new[263]	_	_
30-41	4828-4838	properties	abstract[262]|abstract[263]	new[262]|new[263]	_	_
30-42	4839-4841	of	abstract[262]|abstract[263]	new[262]|new[263]	_	_
30-43	4842-4845	the	abstract[262]|abstract[263]|substance[264]	new[262]|new[263]|giv[264]	coref	31-20[271_264]
30-44	4846-4852	enzyme	abstract[262]|abstract[263]|substance[264]	new[262]|new[263]|giv[264]	_	_
30-45	4853-4854	.	_	_	_	_

#Text=To decipher the high stability of the new haloalkane dehalogenase DmxA wt , we investigated three unique features of the enzyme , corresponding to three possible sources of its stabilization .
31-1	4855-4857	To	_	_	_	_
31-2	4858-4866	decipher	_	_	_	_
31-3	4867-4870	the	abstract[265]	new[265]	_	_
31-4	4871-4875	high	abstract[265]	new[265]	_	_
31-5	4876-4885	stability	abstract[265]	new[265]	_	_
31-6	4886-4888	of	abstract[265]	new[265]	_	_
31-7	4889-4892	the	abstract[265]	new[265]	_	_
31-8	4893-4896	new	abstract[265]	new[265]	_	_
31-9	4897-4907	haloalkane	abstract[265]|substance|abstract[267]	new[265]|new|new[267]	_	_
31-10	4908-4920	dehalogenase	abstract[265]|abstract[267]	new[265]|new[267]	_	_
31-11	4921-4925	DmxA	abstract[265]|abstract	new[265]|giv	coref	34-9
31-12	4926-4928	wt	abstract[265]	new[265]	_	_
31-13	4929-4930	,	_	_	_	_
31-14	4931-4933	we	person	giv	ana	33-9
31-15	4934-4946	investigated	_	_	_	_
31-16	4947-4952	three	abstract[270]	new[270]	_	_
31-17	4953-4959	unique	abstract[270]	new[270]	_	_
31-18	4960-4968	features	abstract[270]	new[270]	_	_
31-19	4969-4971	of	abstract[270]	new[270]	_	_
31-20	4972-4975	the	abstract[270]|substance[271]	new[270]|giv[271]	ana	31-29[0_271]
31-21	4976-4982	enzyme	abstract[270]|substance[271]	new[270]|giv[271]	_	_
31-22	4983-4984	,	abstract[270]	new[270]	_	_
31-23	4985-4998	corresponding	abstract[270]	new[270]	_	_
31-24	4999-5001	to	abstract[270]	new[270]	_	_
31-25	5002-5007	three	abstract[270]|abstract[272]	new[270]|new[272]	_	_
31-26	5008-5016	possible	abstract[270]|abstract[272]	new[270]|new[272]	_	_
31-27	5017-5024	sources	abstract[270]|abstract[272]	new[270]|new[272]	_	_
31-28	5025-5027	of	abstract[270]|abstract[272]	new[270]|new[272]	_	_
31-29	5028-5031	its	abstract[270]|abstract[272]|substance|abstract[274]	new[270]|new[272]|giv|giv[274]	coref	33-13[286_0]
31-30	5032-5045	stabilization	abstract[270]|abstract[272]|abstract[274]	new[270]|new[272]|giv[274]	_	_
31-31	5046-5047	.	_	_	_	_

#Text=Both replacements of glutamine with asparagine and opening of the main tunnel brought desired outcomes in terms of decreased stability and improved activity .
32-1	5048-5052	Both	event[275]	new[275]	_	_
32-2	5053-5065	replacements	event[275]	new[275]	_	_
32-3	5066-5068	of	event[275]	new[275]	_	_
32-4	5069-5078	glutamine	event[275]|substance	new[275]|giv	_	_
32-5	5079-5083	with	event[275]	new[275]	_	_
32-6	5084-5094	asparagine	event[275]|substance	new[275]|giv	_	_
32-7	5095-5098	and	_	_	_	_
32-8	5099-5106	opening	event[278]	new[278]	_	_
32-9	5107-5109	of	event[278]	new[278]	_	_
32-10	5110-5113	the	event[278]|place[279]	new[278]|giv[279]	_	_
32-11	5114-5118	main	event[278]|place[279]	new[278]|giv[279]	_	_
32-12	5119-5125	tunnel	event[278]|place[279]	new[278]|giv[279]	_	_
32-13	5126-5133	brought	_	_	_	_
32-14	5134-5141	desired	event[280]	new[280]	_	_
32-15	5142-5150	outcomes	event[280]	new[280]	_	_
32-16	5151-5153	in	event[280]	new[280]	_	_
32-17	5154-5159	terms	event[280]	new[280]	_	_
32-18	5160-5162	of	event[280]	new[280]	_	_
32-19	5163-5172	decreased	event[280]|abstract[281]|abstract[282]	new[280]|new[281]|giv[282]	_	_
32-20	5173-5182	stability	event[280]|abstract[281]|abstract[282]	new[280]|new[281]|giv[282]	_	_
32-21	5183-5186	and	event[280]|abstract[282]	new[280]|giv[282]	_	_
32-22	5187-5195	improved	event[280]|abstract[282]|abstract[283]	new[280]|giv[282]|giv[283]	_	_
32-23	5196-5204	activity	event[280]|abstract[282]|abstract[283]	new[280]|giv[282]|giv[283]	_	_
32-24	5205-5206	.	_	_	_	_

#Text=More importantly , introducing only two mutations , we managed to turn the thermostable enzyme into a mesophilic-like counterpart , with a melting temperature comparable to that of other related HLDs and a significantly improved catalytic performance .
33-1	5207-5211	More	_	_	_	_
33-2	5212-5223	importantly	_	_	_	_
33-3	5224-5225	,	_	_	_	_
33-4	5226-5237	introducing	_	_	_	_
33-5	5238-5242	only	abstract[284]	new[284]	coref	34-7[295_284]
33-6	5243-5246	two	abstract[284]	new[284]	_	_
33-7	5247-5256	mutations	abstract[284]	new[284]	_	_
33-8	5257-5258	,	_	_	_	_
33-9	5259-5261	we	person	giv	ana	34-2
33-10	5262-5269	managed	_	_	_	_
33-11	5270-5272	to	_	_	_	_
33-12	5273-5277	turn	_	_	_	_
33-13	5278-5281	the	substance[286]	giv[286]	coref	34-16[301_286]
33-14	5282-5294	thermostable	substance[286]	giv[286]	_	_
33-15	5295-5301	enzyme	substance[286]	giv[286]	_	_
33-16	5302-5306	into	_	_	_	_
33-17	5307-5308	a	abstract[287]	new[287]	_	_
33-18	5309-5324	mesophilic-like	abstract[287]	new[287]	_	_
33-19	5325-5336	counterpart	abstract[287]	new[287]	_	_
33-20	5337-5338	,	_	_	_	_
33-21	5339-5343	with	_	_	_	_
33-22	5344-5345	a	abstract[289]	giv[289]	ana	33-27[290_289]
33-23	5346-5353	melting	event|abstract[289]	giv|giv[289]	_	_
33-24	5354-5365	temperature	abstract[289]	giv[289]	_	_
33-25	5366-5376	comparable	abstract[289]	giv[289]	_	_
33-26	5377-5379	to	_	_	_	_
33-27	5380-5384	that	abstract[290]	giv[290]	_	_
33-28	5385-5387	of	abstract[290]	giv[290]	_	_
33-29	5388-5393	other	abstract[290]|abstract[291]	giv[290]|giv[291]	_	_
33-30	5394-5401	related	abstract[290]|abstract[291]	giv[290]|giv[291]	_	_
33-31	5402-5406	HLDs	abstract[290]|abstract[291]	giv[290]|giv[291]	_	_
33-32	5407-5410	and	_	_	_	_
33-33	5411-5412	a	abstract[292]	new[292]	_	_
33-34	5413-5426	significantly	abstract[292]	new[292]	_	_
33-35	5427-5435	improved	abstract[292]	new[292]	_	_
33-36	5436-5445	catalytic	abstract[292]	new[292]	_	_
33-37	5446-5457	performance	abstract[292]	new[292]	_	_
33-38	5458-5459	.	_	_	_	_

#Text=If we combined the effects of mutations in DmxA Q/N and DmxA MF/AA variants , the consequent enzyme would result in a highly active catalyst .
34-1	5460-5462	If	_	_	_	_
34-2	5463-5465	we	person	giv	_	_
34-3	5466-5474	combined	_	_	_	_
34-4	5475-5478	the	abstract[294]	new[294]	_	_
34-5	5479-5486	effects	abstract[294]	new[294]	_	_
34-6	5487-5489	of	abstract[294]	new[294]	_	_
34-7	5490-5499	mutations	abstract[294]|abstract[295]|abstract[296]	new[294]|giv[295]|giv[296]	coref	34-7[296_295]
34-8	5500-5502	in	abstract[294]|abstract[295]|abstract[296]	new[294]|giv[295]|giv[296]	_	_
34-9	5503-5507	DmxA	abstract[294]|abstract[295]|abstract[296]|abstract|abstract[298]	new[294]|giv[295]|giv[296]|giv|giv[298]	coref	34-12[299_0]
34-10	5508-5511	Q/N	abstract[294]|abstract[295]|abstract[296]|abstract[298]	new[294]|giv[295]|giv[296]|giv[298]	_	_
34-11	5512-5515	and	abstract[294]|abstract[296]	new[294]|giv[296]	_	_
34-12	5516-5520	DmxA	abstract[294]|abstract[296]|abstract[299]|abstract[300]	new[294]|giv[296]|giv[299]|new[300]	_	_
34-13	5521-5526	MF/AA	abstract[294]|abstract[296]|abstract[299]|abstract[300]	new[294]|giv[296]|giv[299]|new[300]	_	_
34-14	5527-5535	variants	abstract[294]|abstract[296]|abstract[300]	new[294]|giv[296]|new[300]	_	_
34-15	5536-5537	,	_	_	_	_
34-16	5538-5541	the	substance[301]	giv[301]	_	_
34-17	5542-5552	consequent	substance[301]	giv[301]	_	_
34-18	5553-5559	enzyme	substance[301]	giv[301]	_	_
34-19	5560-5565	would	_	_	_	_
34-20	5566-5572	result	_	_	_	_
34-21	5573-5575	in	_	_	_	_
34-22	5576-5577	a	substance[302]	new[302]	_	_
34-23	5578-5584	highly	substance[302]	new[302]	_	_
34-24	5585-5591	active	substance[302]	new[302]	_	_
34-25	5592-5600	catalyst	substance[302]	new[302]	_	_
34-26	5601-5602	.	_	_	_	_
